A project led by The Centre for Process Innovation (CPI) is to examine the commercial viability of marine-derived peptones for high-value products.
The MarineIBand project, being carried out with Norwegian Marine Bioproducts, uses co-products of the salmon processing industry, recovered via an enzymatic hydrolysis method, which represents a cleaner, more efficient alternative to acid hydrolysis.
Aside from the creation of a new range of bio-based products, the Marine Bioproducts approach is to optimise the use of marine resources by utilising more of the co-products.
Marine Bioproducts established a commercial operation based on the sale of pet and livestock feed at the lower end of value chain, but believes its process has potential for the fermentation market.
Around 800,000 tonnes of co-products are generated from fisheries and aquaculture in Norway each year. Approximately 75% of this volume is exploited but only in low-value products.
CPI is carrying out a feasibility study hoping to advance the process to the next level. The study will generate data that supports the case for Marine Bioproduct's peptone to be a viable microbiological media component.
